Previous | 
Home
Section: Partnerships and Cooperations
European Initiatives
FP7 & H2020 Projects
MD PAEDIGREE
-
Partner: Siemens AG (DE), Siemens SCR (USA), Maat France (FR), MOTEK (NL), EMP (DE), VUmc (NL), Lynkeus (IT). Universities: KU Leuven (BE), Fraunhofer (DE), UMC Utrecht (NL), TU Delft(NL), Sheffield (UK), Athens (GR), Genoa (IT), Transilvania din Brasov (RO); Hospitals: OPBG (Roma, IT), Gaslini (Genoa, IT), GOSH/UCL (London, UK), JHU (Baltimore, USA).
-
See also: http://www.md-paedigree.eu/
-
Abstract:MD-Paedigree is a clinically-driven and strongly VPH-rooted project, where 7 world-renowned clinical centres of excellence pursue improved interoperability of paediatric biomedical information, data and knowledge by developing together a set of reusable and adaptable multi-scale models for more predictive, individualised, effective and safer paediatric healthcare, being scientifically and technologically supported by one of the leading industrial actors in medical applications in Europe operating in conjunction with highly qualified SMEs and some of the most experienced research partners in the VPH community. MD-Paedigree validates and brings to maturity patient-specific computer-based predictive models of various paediatric diseases, thus increasing their potential acceptance in the clinical and biomedical research environment by making them readily available not only in the form of sustainable models and simulations, but also as newly-defined workflows for personalised predictive medicine at the point of care. These tools can be accessed and used through an innovative model-driven infostructure powered by an established digital repository solution able to integrate multimodal health data, entirely focused on paediatrics and conceived of as a specific implementation of the VPH-Share project, planned to be fully interoperable with it and cooperating, through it, also with p-Medicine. MD-Paedigree’s goals are to integrate and share highly heterogeneous biomedical information, data and knowledge, using best practices from the biomedical semantic Web; develop holistic search strategies to seamlessly navigate through and manage the integrative model-driven infostructure and digital repository; jointly develop reusable, adaptable and composable multi-scale VPH workflow models, support evidence-based translational medicine at the point of care, and ultimately facilitate collaborations within the VPH community.
VP2HF
-
Partner: Philips Research Hamburg (DE), Universitat Pompeu Fabra (SP), Inria, French National Research Institute in Informatics and Mathematics (FR), Université Catholique de Louvain (BE), Caen University Hospital (FR), Philips Research Paris (FR), Simula Research Laboratory (NO), Centron Diagnostics (UK).
-
See also: http://vp2hf.eu/
-
Abstract: Heart failure (HF) is one of the major health issues in Europe, affecting 6 million patients and growing substantially because of the ageing population and improving survival following myocardial infarction. The poor short to medium term prognosis of these patients means that treatments such as cardiac re-synchronisation therapy and mitral valve repair can have substantial impact. However, these therapies are ineffective in up to 50% of the treated patients and involve significant morbidity and substantial cost. The primary aim of VP2HF is to bring together image and data processing tools with statistical and integrated biophysical models mainly developed in previous VPH projects, into a single clinical workflow to improve therapy selection and treatment optimisation in HF. The tools will be tested and validated in 200 patients (including 50 historical datasets) across 3 clinical sites, including a prospective clinical study in 50 patients in the last year of the project. The key innovations in VP2HF that make it likely that the project results will be commercially exploited and have major clinical impact are: 1) all tools to process images and signals, and obtain the statistical and biophysical models will be integrated into one clinical software platform that can be easily and intuitively used by clinicians and tried out in the prospective clinical study; and 2) by utilising a decision tree stratification approach, only the appropriate parts of the tool chain, that will add maximum value to the predictions, will be used in individual patients, so that the more resource intensive parts will be used when they will add real value. We expect that the study results of substantial improved efficacy of decision making over current guidelines, and an integrated package that is used as part of clinical workflow will ensure the industrial project partners, in particular Philips, will develop project outputs into dedicated products that will have significant clinical impact.
MedYMA
-
Abstract: During the past decades, exceptional progress was made with in vivo medical imaging technologies for capturing the anatomical, structural and physiological properties of tissues and organs in a patient, with an ever increasing spatial and temporal resolution. The physician is now faced with a formidable overflow of information, especially when a time dimension is added to the already hard to integrate 3-D spatial, multimodal and multiscale dimensions of modern medical images. This increasingly hampers the early detection and understanding of subtle image changes which can have a vital impact on the patient's health. To change this situation, this proposal introduces a new generation of computational models for the simulation and analysis of dynamic medical images. Thanks to their enerative nature, they will allow the construction of databases of synthetic, realistic medical image sequences simulating various evolving diseases, producing an invaluable new resource for training and benchmarking. Leveraging their principled biophysical and statistical foundations, these new models will bring remarkable added clinical value after they are personalized with innovative methods to fit the medical images of any specific patient. By explicitly revealing the underlying evolving biophysical processes observable in the images, this approach will yield new groundbreaking image processing tools to correctly interpret the patient's condition (computer aided diagnosis), to accurately predict future evolution (computer aided prognosis), and to precisely simulate and monitor an optimal and personalized therapeutic strategy (computer aided therapy). First applications will concern high impact diseases including brain tumors, Alzheimer's disease, heart failure and cardiac arrhythmia and will open new horizons in computational medical imaging.
Inria International Partners
Stanford, Statistics Department
France Stanford collaborative project grant (2013-2014):Understanding Lower Back Pain through Geometric Statistical Analysis of computed tomography (CT) Images. Stanford, Statistics Dept & Nice Univ. Hospital. Principal investigators X. Pennec (Inria) and S. Holmes (Stanford). Collaboration on statistics on group-valued trees and geometric subspace learning.
Informal International Partners
St Thomas' Hospital, King's College London, United Kingdom
Maxime Sermesant is a visiting lecturer in the Division of Imaging Sciences and Biomedical Engineering, St Thomas' Hospital, King's College London lead by Pr Reza Razavi. The XMR facility within this hospital is a unique opportunity to validate and exploit the cardiovascular modelling work.
Massachusetts General Hospital, Boston
A collaboration with Dr Jan Unklebach, Assistant Professor of Radiation Oncology and Dr Jayashree Kalpathy-Cramer, radiology instructor was initiated in 2013 around the topics of tumor growth modeling, radiotherapy planning and edema characterization from MRI. Matthieu Lê spent 2013 in the department of Radiation Physics at MGH.
Other International Hospitals
Collaborations with several other European hospitals have been established through the European projects VP2HF and MD PAEDIGREE.